02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 4.94
+4.33%Margins
Gross margin
55.5%
EBITDA margin
-77.4%
EBIT margin
-91.8%
Net margin
-98.4%
FCF margin
-65.7%
-32.2%
Return on equity
-20.2%
Return on assets
-23.5%
Return on invested capital
0.25x
Asset turnover
-HKD 327.2M
Cash from operations
HKD 1.32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026